Investor's Alert on Staples, Inc. (NASDAQ:SPLS), Green Innovations Ltd (OTC:GNIN), Cord Blood America Inc. (OTC:CBAI)

Lakeland, FL -- (SBWIRE) -- 02/20/2013 -- Penny Stock Divas is composed of a team of market professionals consisting of research analysts, technical chartists and traders. With over 50 years of combined experience, we work diligently to provide you with accurate information on our best penny stock picks.

Staples, Inc. (NASDAQ:SPLS) during previous trading session the stock showed a positive movement of 13.13%.

Graph values of the stock demonstrate these trends: Year to date performance of the stock remained positive with the rise of 28.51%. The SPLS traded with volume of 68.20 million shares, while its average trading ability remained 10.87 million shares.

Can Investors Bet on SPLS after this News update? Find out in this Research Report

Currently company is having a market capitalization of $9.87 billion. Stock’s closing price was $14.65 while it started its day-trade at $14.76; its 52-week price range was $10.57 - $16.93. Staples, Inc., together with its subsidiaries, operates as an office products company. The company offers various office supplies and services, office machines and related products, computers and related products, and office furniture under Staples, Quill, and other proprietary brands.

Green Innovations Ltd (OTC:GNIN) stock’s trade opened at $2.94 and as day trade closed its price was $1.43 after decreasing-48.00% .The market capitalization of GNIN was 143.00 million. Total traded volume of the stock was 18.24 million shares while company’s average volume remained 1.12 million shares.

Is GNIN a Solid Investment at These Levels? Read This Report For Details

GNIN’s day range remained $1.27 - $3.35 while its 52 week range was $0.17 - $3.35. During last 5 trades the stock jumped almost 19.17%. During last 3 month it rose with the percentage of 741.18. Its year to date performance remained progressive with 150%.Green Innovations Ltd. imports and distributes bamboo-based hygienic and household products under the Brand names Premium Formulation, Clearly Herbal, and Green & Soft. The company was formerly known as Green Hygienics, Inc. and changed its name to Green Innovations Ltd. in September, 2012. Green Innovations Ltd. was incorporated in 2012 and is based in Miami, Florida.

Cord Blood America Inc. (OTC:CBAI) remained among the day gainers and traded with volume of 18.15 million shares in the last session as compared to average volume of 9.88 million shares.

Previous 5 days graph demonstrated an optimistic move of 6.25%. CBAI’s quarterly performance remained red with the percentage of -32, while its year to date performance showed that the stock plunged overall -32%.

How Should Investors Trade CBAI Now? Don’t Miss out a Special Trend Analysis

52 week range of the stock remained $0.0021 - $0.028, while its day lowest price was $0.0027 and its hit its day highest price at $0.0036. CBAI’s total market capitalization is $849,998 along with 250 million shares outstanding. Cord Blood America, Inc., through its subsidiaries, provides private cord blood stem cell preservation services to families throughout the United States and internationally in South America, China, Germany, and Spain.

About Penny Stock Divas
PSD is composed of a team of market professionals consisting of research analysts, technical chartists and traders. With over 50 years of combined experience, we work diligently to provide you with accurate information on our penny stock picks. We use social media tools such as Twitter and Facebook, enabling you to receive time sensitive information in a real-time manner. When you sign up for our FREE penny stock newsletter, you will receive our latest hot penny stock alerts! We have new investment ideas for penny stocks with research and commentary in the penny stock market.

Disclaimer
PSD is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and the company website, but this should not be construed as a recommendation to buy or sell.